Momenta Gets Rivals' Sale Of Generic Lovenox Barred
Massachusetts drugmaker Momenta Pharmaceuticals Inc. on Friday won a preliminary injunction that blocks rivals Watson Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc. and International Medical Systems Ltd. from selling a competing generic version...To view the full article, register now.
Already a subscriber? Click here to view full article